Ping An Healthcare and Technology Company Limited (1833.HK)
HKD 6.5
(0.31%)
HKD 6.5
(0.31%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -243.82 Million CNY | 76.1% |
| 2022 | -1.02 Billion CNY | 42.12% |
| 2021 | -1.76 Billion CNY | -191.25% |
| 2020 | -605.19 Million CNY | 39.8% |
| 2019 | -1 Billion CNY | -12.28% |
| 2018 | -1.26 Billion CNY | 2.82% |
| 2017 | -940.94 Million CNY | -26.34% |
| 2016 | -729.26 Million CNY | -133.08% |
| 2015 | -318.12 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -55.2 Million CNY | 0.0% |
| 2023 FY | - CNY | 76.1% |
| 2023 Q4 | -201.44 Million CNY | 0.0% |
| 2023 Q2 | -418.22 Million CNY | 0.0% |
| 2022 Q2 | -587.83 Million CNY | 0.0% |
| 2022 FY | - CNY | 42.12% |
| 2022 Q4 | -460.86 Million CNY | 0.0% |
| 2021 Q4 | -867.52 Million CNY | 0.0% |
| 2021 FY | - CNY | -191.25% |
| 2021 Q2 | -895.11 Million CNY | 0.0% |
| 2020 FY | - CNY | 39.8% |
| 2020 Q4 | -324.57 Million CNY | 0.0% |
| 2020 Q2 | -280.62 Million CNY | 0.0% |
| 2019 FY | - CNY | -12.28% |
| 2019 Q4 | -614.78 Million CNY | 0.0% |
| 2019 Q2 | -390.54 Million CNY | 0.0% |
| 2018 FY | - CNY | 2.82% |
| 2018 Q4 | -746.54 Million CNY | 0.0% |
| 2018 Q1 | -216.49 Million CNY | 44.13% |
| 2018 Q2 | -514.2 Million CNY | -137.51% |
| 2017 Q4 | -387.46 Million CNY | 0.0% |
| 2017 Q2 | -360.01 Million CNY | -53.04% |
| 2017 Q1 | -235.23 Million CNY | 0.0% |
| 2017 FY | - CNY | -26.34% |
| 2016 FY | - CNY | -133.08% |
| 2016 Q4 | -235.23 Million CNY | 0.0% |
| 2016 Q2 | -182.31 Million CNY | 0.0% |
| 2016 Q1 | -182.31 Million CNY | 0.0% |
| 2015 Q1 | -79.53 Million CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q4 | -182.31 Million CNY | -129.24% |
| 2015 Q3 | -79.53 Million CNY | 0.0% |
| 2015 Q2 | -79.53 Million CNY | 0.0% |
| 2014 Q4 | -79.53 Million CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|